25 May 2013
Keywords: sanofi, presents, athena, trial, results, aha, french
Article | 17 November 2008
French drug major Sanofi-Aventis presented new data from the landmark ATHENA trial, showing that its Multaq (dronedarone) significantly
reduced the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2008
24 May 2013
© 2013 thepharmaletter.com